Relapse in a borderline-tuberculoid case of leprosy 5 years after the release from rifampicin monotherapy.
Shetty
V P
VP
Foundation for Medical Research, Bombay, India.
Antia
N H
NH
D000368:Aged; D001707:Biopsy, Needle; D005260:Female; D006801:Humans; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015439:Leprosy, Borderline / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D015441:Leprosy, Tuberculoid / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D012008:Recurrence; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D007917:Leprostatic Agents; D012293:Rifampin